Sunday, Feb. 28, 1:30 p.m. – 3 p.m., Sibley Medical Building
Hear celebrated retina expert Emily Chew, M.D.
FACT: “Dry” age-related macular degeneration (AMD) affects 80 to 90 percent of people with AMD. Celebrate “AMD Awareness Month” with Emily Chew, M.D., lead investigator of the landmark AREDS2 vitamin study and Deputy Clinical Director at the National Eye Institute (NEI), National Institutes of Health (NIH). She will discuss current dry AMD research initiatives and provide the latest thinking on protecting existing sight. This special event at Sibley Medical Building is Sunday, Feb. 28 at 1:30 p.m. in the first-floor Conference Room 2.
Do you know that dry AMD tends to progress more slowly than the wet type?
In dry age-related macular degeneration, there are various stages of AMD: early, intermediate, and advanced. Understanding the stages of dry AMD is important when considering eye vitamin supplements. In early dry AMD, small white or yellowish deposits called drusen form on the retina beneath the macula, causing it to deteriorate or degenerate over time.
Drusen are the “hallmark” of dry AMD. Typically, when drusen first form, they don’t cause vision loss. However, they are a risk factor for progressing to vision loss. Remember, AMD can occur in one or both eyes. Call your ophthalmologist ASAP if blurring or increased blurring in central vision occurs.